BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2328750)

  • 1. Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium.
    Vlahov V; Badian M; Verho M; Bacracheva N
    Eur J Clin Pharmacol; 1990; 38(1):61-5. PubMed ID: 2328750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation and excretion of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1992; 42(2):187-91. PubMed ID: 1618251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent pharmacokinetics of metabolites of dipyrone in saliva.
    Neddermann E; Rohdewald P
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):105-11. PubMed ID: 3208789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine on the pharmacokinetics of the metabolites of metamizol.
    Bacracheva N; Tyutyulkova N; Drenska A; Gorantcheva J; Schinzel S; Scholl T; Stoinov A; Tchakarski I; Tentcheva J; Vlahov V
    Int J Clin Pharmacol Ther; 1997 Jul; 35(7):275-81. PubMed ID: 9247840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators.
    Levy M; Safadi R; Zylber-Katz E; Granit L; Caraco Y
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):461-5. PubMed ID: 11699610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
    Caraco Y; Zylber-Katz E; Granit L; Levy M
    Arzneimittelforschung; 1993 Nov; 43(11):1204-8. PubMed ID: 8292065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein binding of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1985; 29(1):67-71. PubMed ID: 4054207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of antipyrine metabolites in human plasma by solid-phase extraction and micellar liquid chromatography.
    Carretero I; Vadillo JM; Laserna JJ
    Analyst; 1995 Jun; 120(6):1729-32. PubMed ID: 7604956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone.
    Cohen O; Zylber-Katz E; Caraco Y; Granit L; Levy M
    Eur J Clin Pharmacol; 1998 Sep; 54(7):549-53. PubMed ID: 9832297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma kinetics of dipyrone metabolites in rapid and slow acetylators.
    Levy M; Flusser D; Zylber-Katz E; Granit L
    Eur J Clin Pharmacol; 1984; 27(4):453-8. PubMed ID: 6519153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability of two oral metamizole formulations. Influence of the acetylation phenotype.
    Bacracheva N; Drenska A; Gorantcheva J; Tyutyulkova N; Vlahov V
    Arzneimittelforschung; 1995 Mar; 45(3):282-5. PubMed ID: 7741785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dipyrone, acetylsalicylic acid and acetaminophen on human neutrophil chemotaxis.
    Matzner Y; Drexler R; Levy M
    Eur J Clin Invest; 1984 Dec; 14(6):440-3. PubMed ID: 6441720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of dipyrone and its metabolites.
    Levy M; Zylber-Katz E; Rosenkranz B
    Clin Pharmacokinet; 1995 Mar; 28(3):216-34. PubMed ID: 7758252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic assay for metamizol metabolites in rat plasma: application to pharmacokinetic studies.
    Domínguez-Ramírez AM; Calzadilla PC; Cortés-Arroyo AR; Hurtado Y de la Peña M; López JR; Gómez-Hernández M; López-Muñoz FJ
    J Pharm Biomed Anal; 2012 Dec; 71():173-8. PubMed ID: 22917546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of metamizol and its metabolites in critical-care patients with acute renal dysfunction.
    Heinemeyer G; Gramm HJ; Roots I; Dennhardt R; Simgen W
    Eur J Clin Pharmacol; 1993; 45(5):445-50. PubMed ID: 8112374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of dipyrone in man; role of the administration route.
    Asmardi G; Jamali F
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):121-5. PubMed ID: 4043141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on the pharmacokinetics of dipyrone.
    Zylber-Katz E; Granit L; Stessman J; Levy M
    Eur J Clin Pharmacol; 1989; 36(5):513-6. PubMed ID: 2753071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metamizol--acute overdose with suicidal intent].
    Wolhoff H; Altrogge G; Pola W; Sistovaris N
    Dtsch Med Wochenschr; 1983 Nov; 108(46):1761-4. PubMed ID: 6641523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic investigations of the marker active metabolites 4-methylamino-antipyrine and 4-amino-antipyrine after intramuscular injection of metamizole in healthy piglets.
    Burmańczuk A; Kowalski C; Giorgi M; Owen H; Grabowski T
    J Vet Pharmacol Ther; 2016 Dec; 39(6):616-620. PubMed ID: 27199202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative thin-layer chromatographic estimation of aminophenazone (I.N.N.), 4-methylaminophenazone and 4-aminophenazone in plasma (author's transl)].
    Hüller G; Haustein KO
    Pharmazie; 1981 Aug; 36(8):546-8. PubMed ID: 7291286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.